PDS Biotechnology Corporation

NASDAQ:PDSB

Biotechnology

Healthcare
$0.92 +1.21%

+$0.01 today

Market cap
$51.58M
Beta
1.56
P/E (TTM)
-1.5
EPS (TTM)
-$0.60
52W Low $0.51High $1.67

Volume 5.25M

Average 1.04M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$31.54M

FY 2025 · Annual

Net Income

-$34.50M

FY 2025 · Annual

Income Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Revenue00000
Cost of Revenue0057.33K59.79K0
Gross Profit00(57.33K)(59.79K)0
Gross Margin—————
Research & Development11.25M29.43M27.76M22.57M19.03M
Selling, General & Admin10.18M12.24M15.28M13.7M12.52M
Operating Expenses21.44M41.67M43.05M36.26M31.54M
Depreciation & Amortization5.36K8657.33K59.79K21.84K
EBITDA(21.43M)(40.74M)(40.09M)(33.75M)(30.3M)
EBITDA Margin—————
Operating Income(21.44M)(41.67M)(43.05M)(36.32M)(31.54M)
Operating Margin—————
Interest Income4.35K935.18K2.9M2.52M1.22M
Interest Expense01.32M4.21M4.67M5.34M
Other Income / Expenses4.35K(381.34K)(1.3M)(2.16M)(4.12M)
Income Before Tax(21.43M)(42.05M)(44.35M)(38.48M)(35.67M)
Pre-Tax Margin—————
Income Tax Expense(4.52M)(1.2M)(1.41M)(869.17K)(1.17M)
Net Income(16.92M)(40.85M)(42.94M)(37.61M)(34.5M)
Net Margin—————
EPS (Basic)(0.66)(1.43)(1.39)(1.03)(0.74)
EPS (Diluted)(0.66)(1.43)(1.39)(1.03)(0.74)
Weighted Avg Shares25.6M28.6M30.95M36.45M46.38M
Weighted Avg Shares (Diluted)25.6M28.6M30.95M36.45M46.38M

PDSB Earnings Waterfall · TTM

NASDAQ:PDSB · Revenue to Net Income

Key Ratios

EPS$-0.67
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-1.3
P/S Ratio0.0

Analysis

$0 of revenue converted into -$33.4M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-0.67, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipOct 21, 2026
8-KCurrent reportOct 21, 2026
3Initial statement of beneficial ownershipOct 21, 2026
3Initial statement of beneficial ownershipOct 20, 2026
4Statement of changes in beneficial ownershipOct 20, 2026

How much revenue does PDSB generate?

PDS Biotechnology Corporation (PDSB) reported $0.00 of revenue in fiscal 2025.

Is PDSB profitable?

PDS Biotechnology Corporation (PDSB) reported -$34.50M of net income.